Ambulatory continuous interscalene nerve blocks decrease the time to discharge readiness after total shoulder arthroplasty: a randomized, triple-masked, placebo-controlled study
Brian M Ilfeld, Krista Vandenborne, Pamela W Duncan, Daniel I Sessler, F Kayser Enneking, Jonathan J Shuster, Douglas W Theriaque, Terese L Chmielewski, Eugene H Spadoni, Thomas W Wright, Brian M Ilfeld, Krista Vandenborne, Pamela W Duncan, Daniel I Sessler, F Kayser Enneking, Jonathan J Shuster, Douglas W Theriaque, Terese L Chmielewski, Eugene H Spadoni, Thomas W Wright
Abstract
Background: A continuous interscalene nerve block (CISB) may be used to provide analgesia after shoulder arthroplasty. Therefore, inpatient stays may be shortened if CISB (1) provides adequate analgesia without intravenous opioids and (2) improves shoulder mobilization. This study investigated the relationship between ambulatory CISB and the time to reach three discharge criteria after shoulder arthroplasty.
Methods: Preoperatively, patients received a CISB. All patients received a perineural 0.2% ropivacaine infusion from surgery until 06:00 the following morning, at which time they were randomly assigned either to continue perineural ropivacaine or to switch to normal saline. The primary endpoint was the time from the end of surgery until three discharge criteria were attained (adequate analgesia, independence from intravenous analgesics, and tolerance to 50% of shoulder motion targets). Patients were discharged home as early as the afternoon after surgery with their CISB using a portable infusion pump.
Results: Patients receiving perineural ropivacaine (n = 16) attained all three discharge criteria in a median (10th-90th percentiles) of 21 (16-41) h, compared with 51 (37-90) h for those receiving perineural normal saline (n = 13, P < 0.001). Unlike patients receiving perineural ropivacaine, patients receiving perineural normal saline often required intravenous morphine, but still experienced a higher degree of pain and tolerated less external rotation.
Conclusions: An ambulatory CISB considerably decreases the time until readiness for discharge after shoulder arthroplasty, primarily by providing potent analgesia that permits greater passive shoulder movement and the avoidance of intravenous opioids. Additional research is required to define the appropriate subset of patients and assess the incidence of complications associated with earlier discharge.
Source: PubMed
Tulevat kliiniset tutkimukset
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and...Ei vielä rekrytointiaMotoriset taidot | Terve | Johtava toiminta
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCEi vielä rekrytointia
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaEi vielä rekrytointiaNivelreuma | Polven rappeuttava nivelsairausItalia
-
University of Wisconsin, MadisonAlkermes, Inc.Ei vielä rekrytointia
-
Virginia Commonwealth UniversityEi vielä rekrytointia
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at...Ei vielä rekrytointiaKetamiini | fMRI | Masennus – vakava masennus | rTMS | Hoitoresistentti masennus (TRD)Yhdysvallat
-
Weill Medical College of Cornell UniversityBD2 LLCEi vielä rekrytointiafMRI | Kaksisuuntainen mielialahäiriö (BD) | rTMS | Kaksisuuntainen mielialahäiriö 1Yhdysvallat
-
Xentria, Inc.Ei vielä rekrytointia
-
Yale UniversityNational Institute of Mental Health (NIMH)Ei vielä rekrytointia
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRekrytointiFeokromosytooma | Feokromosytooma/paragangliooma | Feokromosytooma, metastaattinen | Pahanlaatuinen feokromosytooma | Feokromosytooma ja paraganglioma (PPGL)Yhdistynyt kuningaskunta
-
Carl Zeiss Meditec-Dublin CoCeRekrytointiEpiretinaalinen kalvo | Verkkokalvon sairaus | Kuivaan ikään liittyvä silmänpohjan rappeuma | Vitreoretinaalinen poikkeavuus | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal...Yhdysvallat
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical UniversityRekrytointiCLDN18.2 Positiiviset kiinteät kasvaimetKiina